Results 271 to 280 of about 471,041 (312)
Some of the next articles are maybe not open access.
Journal of Neurology, 2014
Stroke disease is the second leading cause of death in the world. Even if stroke incidence remains stable, the number of new acute strokes in Europe is projected to increase markedly by 2025. In 2007, the SITS-MOST trial provided the first conclusive evidence that intravenous thrombolysis with recombinant tissue plasminogen activator (rTPA) was ...
E C, Tallantyre, N P, Robertson
openaire +2 more sources
Stroke disease is the second leading cause of death in the world. Even if stroke incidence remains stable, the number of new acute strokes in Europe is projected to increase markedly by 2025. In 2007, the SITS-MOST trial provided the first conclusive evidence that intravenous thrombolysis with recombinant tissue plasminogen activator (rTPA) was ...
E C, Tallantyre, N P, Robertson
openaire +2 more sources
New England Journal of Medicine, 2020
Key Clinical Points Acute Ischemic Stroke Treatment for patients with acute ischemic stroke is guided by the time from the onset of stroke, the severity of neurologic deficit, and findings on neuro...
openaire +2 more sources
Key Clinical Points Acute Ischemic Stroke Treatment for patients with acute ischemic stroke is guided by the time from the onset of stroke, the severity of neurologic deficit, and findings on neuro...
openaire +2 more sources
AACN Advanced Critical Care, 2018
Acute ischemic stroke is a major cause of mortality and morbidity in the United States and worldwide. Despite the development of specialized stroke centers, mortality and morbidity as a result of acute ischemic strokes can and do happen anywhere. These strokes are emergency situations requiring immediate intervention.
Bryan, Boling, Katie, Keinath
openaire +2 more sources
Acute ischemic stroke is a major cause of mortality and morbidity in the United States and worldwide. Despite the development of specialized stroke centers, mortality and morbidity as a result of acute ischemic strokes can and do happen anywhere. These strokes are emergency situations requiring immediate intervention.
Bryan, Boling, Katie, Keinath
openaire +2 more sources
Surgical Neurology, 1996
It is likely that thrombolytic agents will play a role in the management of acute ischemic stroke in well-selected patients, intravenous administration is most practicable. However, intra-arterial administration via superselective catheterization is an alternative option that may offer advantages is certain settings (e.g., angiography suite ...
openaire +2 more sources
It is likely that thrombolytic agents will play a role in the management of acute ischemic stroke in well-selected patients, intravenous administration is most practicable. However, intra-arterial administration via superselective catheterization is an alternative option that may offer advantages is certain settings (e.g., angiography suite ...
openaire +2 more sources
Journal of Stroke and Cerebrovascular Diseases, 1999
Stroke (both ischemic and hemorrhagic) is considered the third leading cause of death in America, and perhaps more importantl~ the leading cause of disability. Stroke occurs once every 45 seconds (approximately 700,000 annuall~ 1,918 dail~ 80 per hour) in the United States.
openaire +2 more sources
Stroke (both ischemic and hemorrhagic) is considered the third leading cause of death in America, and perhaps more importantl~ the leading cause of disability. Stroke occurs once every 45 seconds (approximately 700,000 annuall~ 1,918 dail~ 80 per hour) in the United States.
openaire +2 more sources
Acute Stroke Treatment: Thrombolysis
Cerebrovascular Diseases, 2000Acute stroke treatment ...
Bogousslavsky J. +2 more
openaire +2 more sources
2002
The reduction of blood flow to parts of the brain is the cause of ischemic stroke leading to functional deficits and, if prolonged, to irreversible neurological and morphological defects. The fast reperfusion, therefore is the most important therapeutic strategy and was proven to be effective in clinical trials.
openaire +3 more sources
The reduction of blood flow to parts of the brain is the cause of ischemic stroke leading to functional deficits and, if prolonged, to irreversible neurological and morphological defects. The fast reperfusion, therefore is the most important therapeutic strategy and was proven to be effective in clinical trials.
openaire +3 more sources
Cerebrovascular Diseases, 2001
The utility of diagnostic imaging during the critical first few hours after stroke onset has many important applications. First and foremost, imaging technologies that can reliably detect and quantify the location of acute stroke will greatly enhance the clinician’s ability to accurately diagnose individual stroke patients.
Moonis, Majaz, Fisher, Marc
openaire +4 more sources
The utility of diagnostic imaging during the critical first few hours after stroke onset has many important applications. First and foremost, imaging technologies that can reliably detect and quantify the location of acute stroke will greatly enhance the clinician’s ability to accurately diagnose individual stroke patients.
Moonis, Majaz, Fisher, Marc
openaire +4 more sources
Archives of Neurology, 1996
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +3 more sources
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +3 more sources